Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
OptiNose, Inc. - Common Stock
(NQ:
OPTN
)
5.510
UNCHANGED
Streaming Delayed Price
Updated: 9:30 AM EST, Feb 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
223
Open
5.510
Bid (Size)
5.310 (4)
Ask (Size)
5.770 (1)
Prev. Close
5.510
Today's Range
5.510 - 5.510
52wk Range
4.815 - 31.50
Shares Outstanding
53,309,012
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Monday's pre-market session: top gainers and losers
February 10, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 10, 2025
Via
Benzinga
Performance
YTD
-17.76%
-17.76%
1 Month
+9.76%
+9.76%
3 Month
-27.58%
-27.58%
6 Month
-59.84%
-59.84%
1 Year
-71.08%
-71.08%
More News
Read More
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
January 15, 2025
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Insights Ahead: OptiNose's Quarterly Earnings
November 11, 2024
Via
Benzinga
Optinose Announces 1-for-15 Reverse Stock Split
December 26, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
December 02, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
November 12, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
November 05, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 16, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Appoints Terry Kohler as Chief Financial Officer
October 07, 2024
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery
September 05, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024
From
Optinose, Inc.
Via
GlobeNewswire
OPTN Stock Earnings: OptiNose Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
August 08, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
August 02, 2024
From
Optinose, Inc.
Via
GlobeNewswire
7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million
July 02, 2024
Via
InvestorPlace
Expanded Access to XHANCE with Addition to National Commercial Formularies
June 27, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
May 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
May 14, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
May 10, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.